KASE's Management Board takes decision on inclusion of ordinary shares US7170811035 (US_PFE_) of Pfizer Inc. in category "standard" of KASE official list's main market

/KASE, March 12, 2019/ – Following a decision of Kazakhstan Stock Exchange (KASE) Management Board dated March 12, 2019, ordinary shares US7170811035 of Pfizer Inc. (US) were included in the category "standard" of KASE official list's main market. The admittance initiator for these shares is Freedom Finance JSC (Almaty). The effective date of said decision of the Management Board will be communicated later as soon as the admittance initiator fulfills terms of item 1 of chapter 5 of appendix 2.3 to KASE's internal document "Listing Rules". Opening of trading in said shares on KASE will also be communicated later. The number of authorized ordinary shares of Pfizer Inc. makes up 12,000,000,000 pieces. As of February 11, 2019 5,780,475,000 ordinary shares were outstanding. Said shares are listed on New York Stock Exchange (NYSE, US). Holders of ordinary shares have the voting right at shareholders' meetings and the right to receiving dividends. Said shares were assigned an abbreviation (ticker) US_PFE_. Main activity of Pfizer Inc. is pharmaceutical business. Details of said share issuance will be released on KASE website after coming into effect of said decision of the Management Board. [2019-03-12]